Infantile achalasia cardia: A rare case report of a 3-month-old female with recurrent pneumonia successfully treated with surgical intervention
Abstract
Introduction Achalasia, a rare esophageal disorder with an annual incidence of 0.11 per 100,000 in children, is characterized by impaired lower esophageal sphincter (LES) relaxation and peristalsis. Infantile cases are extremely uncommon and often linked to genetic conditions like Allgrove and Down syndrome. Diagnosis is challenging due to overlapping symptoms with other pediatric conditions, relying on barium esophagography and esophageal manometry. Heller myotomy remains the preferred surgical treatment to reduce LES pressure. Case presentation A 3-month-old female presented with a history of cough, feeding difficulties, and regurgitation, accompanied by respiratory distress and recurrent pneumonia. She was diagnosed with achalasia cardia based on clinical findings and contrast-enhanced esophagography. A modified Heller myotomy with Dor-fundoplication was performed successfully, with no postoperative complications. The patient was discharged in stable condition. Discussion Infantile achalasia, a rare condition with unclear etiology, often presents diagnostic challenges. Our early-onset case, lacking syndromic associations, was complicated by recurrent pneumonia, necessitating surgical intervention. The successful outcome after a modified Heller myotomy with Dor-fundoplication supports its efficacy in severe pediatric cases, though long-term monitoring for recurrence is essential. Conclusion Achalasia cardia, though rare in infants, should be considered as differential in…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 100,000 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.